Skip to content
10-Q

Quarterly Report

Viracta Therapeutics, Inc.

0000950170-24-096982

← back to feed
Filed
Aug 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 5, 2024 39.42M sh
Shares Diluted Q2 2024 · Jun 30, 2024 39.4M sh
Shares Diluted Q2 2024 · Jun 30, 2024 39.36M sh
Shares Diluted Q2 2024 · Jun 30, 2023 38.56M sh
Shares Diluted Q2 2024 · Jun 30, 2023 38.51M sh
Capex Q2 2024 · Jun 30, 2024 $0
Capex Q2 2024 · Jun 30, 2023 $189K
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$17.68M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$19.33M
Short Term Debt Q2 2024 · Jun 30, 2024 $18.75M
Short Term Debt Q2 2024 · Dec 31, 2023 $25.27M
Short Term Investments Q2 2024 · Jun 30, 2024 $16.02M
Short Term Investments Q2 2024 · Dec 31, 2023 $41.37M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $13.98M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $12.32M
Stockholders Equity Q2 2024 · Jun 30, 2024 $2.67M
Stockholders Equity Q2 2024 · Mar 31, 2024 $11.08M
Stockholders Equity Q2 2024 · Dec 31, 2023 $18.32M
Stockholders Equity Q2 2024 · Jun 30, 2023 $40.78M
Stockholders Equity Q2 2024 · Mar 31, 2023 $51.11M
Stockholders Equity Q2 2024 · Dec 31, 2022 $61.1M
Current Liabilities Q2 2024 · Jun 30, 2024 $28.65M
Current Liabilities Q2 2024 · Dec 31, 2023 $38.37M
Total Liabilities Q2 2024 · Jun 30, 2024 $28.65M
Total Liabilities Q2 2024 · Dec 31, 2023 $38.37M
Current Assets Q2 2024 · Jun 30, 2024 $31.07M
Current Assets Q2 2024 · Dec 31, 2023 $54.96M
Total Assets Q2 2024 · Jun 30, 2024 $31.32M
Total Assets Q2 2024 · Dec 31, 2023 $56.69M
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.25
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.48
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.32
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.64
Eps Basic Q2 2024 · Jun 30, 2024 −$0.25
Eps Basic Q2 2024 · Jun 30, 2024 −$0.48
Eps Basic Q2 2024 · Jun 30, 2023 −$0.32
Eps Basic Q2 2024 · Jun 30, 2023 −$0.64
Sga Expense Q2 2024 · Jun 30, 2024 $3.04M
Sga Expense Q2 2024 · Jun 30, 2024 $6.96M
Sga Expense Q2 2024 · Jun 30, 2023 $4.25M
Sga Expense Q2 2024 · Jun 30, 2023 $8.85M
Net Income Q2 2024 · Jun 30, 2024 −$9.83M
Net Income Q2 2024 · Jun 30, 2024 −$18.97M
Net Income Q2 2024 · Mar 31, 2024 −$9.14M
Net Income Q2 2024 · Jun 30, 2023 −$12.48M
Net Income Q2 2024 · Jun 30, 2023 −$24.69M
Net Income Q2 2024 · Mar 31, 2023 −$12.21M
Operating Income Q2 2024 · Jun 30, 2024 −$9.59M
Operating Income Q2 2024 · Jun 30, 2024 −$23.47M
Operating Income Q2 2024 · Jun 30, 2023 −$12.45M
Operating Income Q2 2024 · Jun 30, 2023 −$24.66M